地佐辛预防瑞芬太尼复合麻醉患者术后疼痛的临床价值河南省商丘市中心医院

• 药品评价-循证医学研究 • 上一篇下一篇

地佐辛预防瑞芬太尼复合麻醉患者术后疼痛的临床价值河南省商丘市中心医院

方艳丽

河南省商丘市中心医院

收稿日期:2013-02-25 修回日期:2013-03-15 出版日期:2013-02-25 发布日期:2013-01-25

Clinical value of dezocine preventing pain after remifentanil-based anesthesia

fangyanli

Shangqiu Central Hospital of Henan Province

Received:2013-02-25 Revised:2013-03-15 Online:2013-02-25 Published:2013-01-25

摘要/Abstract

摘要： 目的对应用地佐辛预防接受瑞芬太尼复合麻醉的患者出现术后疼痛的临床效果进行研究。方法抽取88例接受瑞芬太尼复合麻醉的患者,随机分为对照组和观察组,平均每组44例。采用芬太尼预防对照组患者出现术后疼痛；采用地佐辛预防观察组患者出现术后疼痛。结果观察组患者术后两个不同时间段的VAS评分均明显低于对照组；苏醒时间和拔管时间明显短于对照组；术后出现不练反应的人数明显少于对照组。结论应用地佐辛预防接受瑞芬太尼复合麻醉的患者出现术后疼痛的临床效果非常明显。

Abstract: objective to prevent patients with remifentanil combined anesthesia the clinical effect of postoperative pain to study the application of dezocine. Methods 88 patients who received remifentanil anesthesia, were randomly divided into control group and observation group, 44 cases each of. Using fentanyl prevention control group patients had postoperative pain; dezocine and prevent the observation group patients experienced postoperative pain. Results the observation group patients after two different period of the VAS score were significantly lower than those in the control group; the recovery time and extubation time was significantly shorter than the control group; after operation number is not practiced responses are significantly less than the control group. Conclusion dezocine prevention in patients undergoing remifentanil combined anesthesia of the postoperative clinical effect is very obvious pain.

方艳丽. 地佐辛预防瑞芬太尼复合麻醉患者术后疼痛的临床价值河南省商丘市中心医院[J]. .

fangyanli. Clinical value of dezocine preventing pain after remifentanil-based anesthesia[J]. .